Re-emergence of HIV after stopping therapy. [Nature. 1999] - PubMed

Recovering from the ravages HIV. [Science. 1997]
Recovering from the ravages HIV.
Cohen J. Science. 1997 Jul 4; 277(5322):33.
Down or out in blood and lymph? [Nature. 1997]
Down or out in blood and lymph?
Wain-Hobson S. Nature. 1997 May 8; 387(6629):123-4.
Absence of detectable viremia in a perinatally HIV-1-infected teenager after discontinuation of antiretroviral therapy. [J Allergy Clin Immunol. 2006]
Absence of detectable viremia in a perinatally HIV-1-infected teenager after discontinuation of antiretroviral therapy.
Feeney ME, Tang Y, Rathod A, Kneut C, McIntosh K. J Allergy Clin Immunol. 2006 Aug; 118(2):324-30. Epub 2006 Jul 3.
Review [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications]. [Bull Acad Natl Med. 2008]
Review [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
Theze J. Bull Acad Natl Med. 2008 Oct; 192(7):1453-66; discussion 1466-8.
Review The potential role of interleukin-2 in HIV. [AIDS. 2001]
Review The potential role of interleukin-2 in HIV.
Mitsuyasu RT. AIDS. 2001 Feb; 15 Suppl 2:S22-7.

Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter. [Retrovirology. 2011]
Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter.
van der Sluis RM, Pollakis G, van Gerven ML, Berkhout B, Jeeninga RE. Retrovirology. 2011 Sep 16; 8:73. Epub 2011 Sep 16.
Rapid turnover of 2-LTR HIV-1 DNA during early stage of highly active antiretroviral therapy. [PLoS One. 2011]
Rapid turnover of 2-LTR HIV-1 DNA during early stage of highly active antiretroviral therapy.
Zhu W, Jiao Y, Lei R, Hua W, Wang R, Ji Y, Liu Z, Wei F, Zhang T, Shi X, et al. PLoS One. 2011; 6(6):e21081. Epub 2011 Jun 8.
Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors. [PLoS One. 2011]
Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors.
Cellerai C, Harari A, Stauss H, Yerly S, Geretti AM, Carroll A, Yee T, Ainsworth J, Williams I, Sweeney J, et al. PLoS One. 2011 Apr 5; 6(4):e18164. Epub 2011 Apr 5.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Re-emergence of HIV after stopping therapy.
Re-emergence of HIV after stopping therapy.
Nature. 1999 Oct 28 ;401(6756):874-5.

PubMed
[Thyroid-intestinal motility interactions summary].
[Thyroid-intestinal motility interactions summary].
Minerva Gastroenterol Dietol. 2004 Dec ;50(4):305-15.

PubMed
Reductions in risk behaviour provide the most consistent explanation for declini...
Reductions in risk behaviour provide the most consistent explanation for declining HIV-1 prevalence in Uganda.
AIDS. 1999 Feb 25 ;13(3):391-8.

PubMed
Membrane association and multimerization of TcpT, the cognate ATPase ortholog of...
Membrane association and multimerization of TcpT, the cognate ATPase ortholog of the Vibrio cholerae toxin-coregulated-pilus biogenesis apparatus.
J Bacteriol. 2007 Jun ;189(12):4401-9. Epub 2007 Apr 13 .

PubMed
The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor sign...
The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling.
Nat Immunol. 2008 Sep ;9(9):1028-36.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed